Debt-to-equity of iTeos Therapeutics, Inc. from 31 Mar 2021 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
iTeos Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2021 to 30 Jun 2025.
  • iTeos Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Jun 2025 was 18%, a 24% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

iTeos Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2025 18% +3% +24% 30 Jun 2025
Q1 2025 15% +1% +4.1% 31 Mar 2025
Q4 2024 15% +2% +12% 31 Dec 2024
Q3 2024 15% +2% +16% 30 Sep 2024
Q2 2024 15% -1% -3.8% 30 Jun 2024
Q1 2024 15% -4% -23% 31 Mar 2024
Q4 2023 13% -11% -46% 31 Dec 2023
Q3 2023 13% -23% -64% 30 Sep 2023
Q2 2023 15% -43% -74% 30 Jun 2023
Q1 2023 19% -43% -69% 31 Mar 2023
Q4 2022 25% -36% -59% 31 Dec 2022
Q3 2022 36% -12% -25% 30 Sep 2022
Q2 2022 59% +52% +758% 30 Jun 2022
Q1 2022 62% +54% +724% 31 Mar 2022
Q4 2021 61% 31 Dec 2021
Q3 2021 48% 30 Sep 2021
Q2 2021 7% 30 Jun 2021
Q1 2021 7% 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.